Table 2.
Differences between the Treatment Planning System dose calculations and the TLD and film gamma analyses.
| HEAD | LIVER | LUNG | PROSTATE | SPINE | |
|---|---|---|---|---|---|
| TLD | |||||
| ECLIPSE | 0.99 | 0.95 | 0.97 | 0.96 | 0.98 |
| IN-HOUSE | 1.01 | 0.93 | 0.95 | 0.99 | 0.94 |
| RAYSTATION | 0.97 | 0.97 | 0.95 | 0.98 | - |
| XIO | 1.00 | 0.96 | 0.96 | 0.96 | 0.98 |
| ANOVA P-VALUE | 0.072 | 0.214 | 0.133 | 0.006* | 0.035* |
| Gamma | |||||
| ECLIPSE | 97 | 78 | 91 | 93 | N/A |
| IN-HOUSE | 96 | 86 | 71 | 87 | N/A |
| RAYSTATION | 96 | 98 | 84 | 99 | N/A |
| XIO | 97 | 91 | 87 | 89 | N/A |
| KRUSKAL-WALLIS P-VALUE | 0.692 | 0.096 | 0.048* | 0.015* | N/A |
*
Indicates analysis was statistically significant with p<0.05.